Induction of primary immune responses by allogeneic human myoblasts: Dissection of the cell types required for proliferation, IFNγ secretion and cytotoxicity

Journal of Neuroimmunology

Volumn 86, Issue 1, 1998, Pages 53-62

  Curnow, S John ^a   Willcox, Nick ^a   Vincent, Angela ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Antigen presentation; Myasthenia gravis; Myoblasts; Polymyositis; Transplantation

Indexed keywords

B7 ANTIGEN; FAS ANTIGEN; GAMMA INTERFERON; IMMUNOSTIMULATING AGENT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; ARTICLE; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MONONUCLEAR CELL; MYASTHENIA GRAVIS; MYOBLAST; POLYMYOSITIS; PRIORITY JOURNAL;

ANTIGEN PRESENTATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELLS, CULTURED; HUMANS; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MUSCLE FIBERS; MYASTHENIA GRAVIS; NEUROIMMUNOMODULATION; POLYMYOSITIS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032101243     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00013-7     Document Type: Article

References (34)

1. Aliprantis A.O., Diez-Roux G., Mulder L.C., Zychlinsky A., Lang R.A. Do macrophages kill through apoptosis? Immunol. Today. 17:1996;573-576.
2. Ansari A.A., Wang Y.C., Kanter K., Villinger F., Mayne A., Sell K.W., Herskowitz A. Host T-cell primary allosensitization to MHC class-I- and class-II-expressing human cardiac myocytes requires the presence of a second signal. Hum. Immunol. 37:1993;108-118.
3. Baggi F., Nicolle M., Vincent A., Matsuo H., Willcox N., Newsom-Davis J. Presentation of endogenous acetylcholine receptor epitope by an MHC class II-transfected human muscle cell line to a specific CD4+ T cell clone from a myasthenia gravis patient. J. Neuroimmunol. 46:1993;57-65.
4. Bal V., McIndoe A., Denton G., Hudson D., Lombardi G., Lamb J., Lechler R. Antigen presentation by keratinocytes induces tolerance in human T cells. Eur. J. Immunol. 20:1990;1893-1897.
5. Bartoccioni E., Gallucci S., Scuderi F., Ricci E., Servidei S., Broccolini A., Tonali P. MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies. Clin. Exp. Immunol. 95:1994;166-172.
6. Bender A., Ernst N., Iglesias A., Dornmair K., Wekerle H., Hohlfeld R. T cell receptor repertoire in polymyositis: clonal expansion of autoaggressive CD8+ T cells. J. Exp. Med. 181:1995;1863-1868.
7. Benichou G., Tam R.C., Soares L.R., Fedoseyeva E.V. Indirect T-cell allorecognition: perspectives for peptide-based therapy in transplantation. Immunol. Today. 18:1997;67-71.
8. Corr M., Lee D.J., Carson A., Tighe H. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med. 184:1996;1555-1560.
9. Coulombe M., Yang H., Guerder S., Flavell R.A., Lafferty K.J., Gill R.G. Tissue immunogenicity: the role of MHC antigen and the lymphocyte costimulator B7-1. J. Immunol. 157:1996;4790-4795.
10. Deeths M.J., Mescher M.F. B7-1-dependent co-stimulation results in qualitatively different responses by CD4+ and CD8+ T cells. Eur. J. Immunol. 27:1997;598-608.
11. Durie F.H., Foy T.M., Masters S.R., Laman J.D., Noelle R.J. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol. Today. 15:1994;406-411.
12. Garlepp M.J., Chen W., Tabarias H., Baines M., Brooks A., McCluskey J. Antigen processing and presentation by a murine myoblast cell line. Clin. Exp. Immunol. 102:1995;614-619.
13. Goebels N., Michaelis D., Wekerle H., Hohlfeld R. Human myoblasts as antigen-presenting cells. J. Immunol. 149:1992;661-667.
14. Guerette B., Asselin I., Vilquin J.T., Roy R., Tremblay J.P. Lymphocyte infiltration following allo- and xenomyoblast transplantation in mdx mice. Muscle Nerve. 18:1995;39-51.
15. + cytotoxic T lymphocytes in the absence of exogenous help. J. Exp. Med. 177:1993;1791-1796.
16. Hohlfeld R., Engel A.G. The immunobiology of muscle. Immunol. Today. 15:1994;269-274.
17. Hohlfeld R., Engel A.G. Induction of HLA-DR expression on human myoblasts with interferon-gamma. Am. J. Pathol. 136:1990;503-508.
18. Hohlfeld R., Engel A.G. Lysis of myotubes by alloreactive cytotoxic T cells and natural killer cells. Relevance to myoblast transplantation. J. Clin. Invest. 86:1990;370-374.
19. Lau H.T., Yu M., Fontana A., Stoeckert C.J. Jr. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science. 273:1996;109-112.
20. Lenschow D.J., Walunas T.L., Bluestone J.A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:1996;233-258.
21. Lindberg C., Oldfors A., Tarkowski A. Local T-cell proliferation and differentiation in inflammatory myopathies. Scand. J. Immunol. 41:1995;421-426.
22. Liu Y., Linsley P.S. Costimulation of T-cell growth. Curr. Opin. Immunol. 4:1992;265-270.
23. Lombardi G., Arnold K., Uren J., Marelli-Berg F., Hargreaves R., Imami N., Weetman A., Lechler R. Antigen presentation by interferon-gamma-treated thyroid follicular cells inhibits interleukin-2 (IL-2) and supports IL-4 production by B7-dependent human T cells. Eur. J. Immunol. 27:1997;62-71.
24. Mantegazza R., Gebbia M., Mora M., Barresi R., Bernasconi P., Baggi F., Cornelio F. Major histocompatibility complex class II molecule expression on muscle cells is regulated by differentiation: implications for the immunopathogenesis of muscle autoimmune diseases. J. Neuroimmunol. 68:1996;53-60.
25. Marelli-Berg F.M., Hargreaves R.E., Carmichael P., Dorling A., Lombardi G., Lechler R.I. Major histocompatibility complex class II-expressing endothelial cells induce allospecific nonresponsiveness in naive T cells. J. Exp. Med. 183:1996;1603-1612.
26. Mendell J.R., Kissel J.T., Amato A.A., King W., Signore L., Prior T.W., Sahenk Z., Benson S., McAndrew P.E., Rice R.et al. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. New Engl. J. Med. 333:1995;832-838.
27. Michaelis D., Goebels N., Hohlfeld R. Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubes. Am. J. Pathol. 143:1993;1142-1149.
28. Mountz J.D., Zhou T., Su X., Wu J., Cheng J. The role of programmed cell death as an emerging new concept for the pathogenesis of autoimmune diseases. Clin. Immunol. Immunopathol. 80:1996;S2-S14.
29. Nagata S., Golstein P. The Fas death factor. Science. 267:1995;1449-1456.
30. Savage C.O., Hughes C.C., McIntyre B.W., Picard J.K., Pober J.S. Human CD4+ T cells proliferate to HLA-DR+ allogeneic vascular endothelium. Identification of accessory interactions. Transplantation. 56:1993;128-134.
31. Sopper M.M., Hauschka S.D., Hoffman E., Ontell M. Gene complementation using myoblast transfer into fetal muscle. Gene Ther. 1:1994;108-113.
32. Tan P., Anasetti C., Hansen J.A., Melrose J., Brunvand M., Bradshaw J., Ledbetter J.A., Linsley P.S. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J. Exp. Med. 177:1993;165-173.
33. Warrens A.N., Zhang J.Y., Sidhu S., Watt D.J., Lombardi G., Sewry C.A., Lechler R.I. Myoblasts fail to stimulate T cells but induce tolerance. Int. Immunol. 6:1994;847-853.
34. Willcox N. Myasthenia gravis. Curr. Opin. Immunol. 5:1993;910-917.